Accelerate Diagnostics, Inc. (NASDAQ:AXDX) will be hosting a conference call at 4:30 PM eastern time on 5th November 2020, to discuss its 3Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website acceleratediagnostics.com
Earnings Expectation
Accelerate Diagnostics, Inc. is set to announce third quarter earning results on Thursday 5th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, AXDX to report 3Q20 loss of $ 0.33 per share. For the full year, analysts anticipate top line of $ 12.00 million, while looking forward to loss of $ 1.39 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 16.00 million ~ $ 18.00 million
Click Here For More Historical Outlooks Of Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc.
